Skip to main content

Table 1 Baseline clinical characteristics of patients before treatment

From: Magnetic resonance imaging is effective for evaluating the therapeutic effect of tolvaptan on total kidney volume in patients with autosomal dominant polycystic kidney disease

  Age (year) Sex Serum Cr (mg/dL) eGFR (mL/min/1.73m2) CKD stage TKV(ml) Cerebral aneurysm
Case1 37 Male 0.76 92.9 G1A1 788 (−)
Case2 51 Female 0.89 52.7 G3aA1 1070 (−)
Case3 55 Male 1.29 46.5 G3aA1 1756 (−)
Case4 38 Male 1.67 39.0 G3bA1 4060 (+)
Case5 54 Male 1.56 38.0 G3bA1 2165 (−)
Case6 52 Female 1.80 24.3 G4A2 1313 (−)
  1. Cr, creatinine; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; TKV, total kidney volume